2025-04-01 02:51:07
Latest Post
Infosys and Linux Foundation Networking Collaborate to Strengthen Responsible AI for Global Networks
ITC announces strategic acquisition of Pulp & Paper Undertaking of Aditya Birla Real Estate Limited
AGI Greenpac Ltd approves ~ Rs. 700 crore capex
NHPC Ltd updates on 300 MW Bikaner Solar Power Project
Prashant India Ltd enters into agreement for sale with Shantilon Poly Pvt Ltd
Stock Report
Gujarat Themis Biosyn Ltd Q3FY23 net profit declines QoQ to Rs. 9.80 crores
Posted On : 2023-02-03 12:17:31( TIMEZONE : IST )
GUJARAT THEMIS BIOSYN LTD. has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 29.9713 crores during the period ended December 31, 2022 as compared to Rs. 49.0873 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 9.8074 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 18.6990 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 6.75 for the period ended December 31, 2022 as compared to Rs. 12.87 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹29.9713 crs | ₹49.0873 crs |  -38.94% |
| Net Profit | ₹9.8074 crs | ₹18.6990 crs | -47.55% |
| EPS | ₹6.75 | ₹12.87 | -47.55% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.29.9713 crores during the period ended December 31, 2022 as compared to Rs.19.2968 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.9.8074 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.7.1206 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.6.75 for the period ended December 31, 2022 as compared to Rs.4.90 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹29.9713 crs | ₹19.2968 crs |  55.32% |
| Net Profit | ₹9.8074 crs | ₹7.1206 crs | 37.73% |
| EPS | ₹6.75 | ₹4.90 | 37.76% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.125.4255 crores during the 9 Months period ended December 31, 2022 as compared to Rs.88.6316 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.46.2767 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.33.8353 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.31.85 for the 9 Months period ended December 31, 2022 as compared to Rs.23.29 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹125.4255 crs | ₹88.6316 crs | 41.51% |
| Net Profit | ₹46.2767 crs | ₹33.8353 crs | 36.77% |
| EPS | ₹31.85 | ₹23.29 | 36.75% |
Shares of GUJARAT THEMIS BIOSYN LTD. was last trading in BSE at Rs. 739.95 as compared to the previous close of Rs. 726.85. The total number of shares traded during the day was 2806 in over 247 trades.
The stock hit an intraday high of Rs. 745.00 and intraday low of 719.55. The net turnover during the day was Rs. 2063478.00.
